These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 14347)

  • 21. Tolerance to the hypothermic effects of 9-tetrahydrocannabinol as a function of age in the chicken.
    Abel EL; McMillan DE; Harris LS
    Br J Pharmacol; 1973 Mar; 47(3):452-6. PubMed ID: 4730826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed ethanol effects on physiological and behavioral indices in the rat.
    Holloway FA; Miller JM; King DA; Bedingfield JB
    Alcohol; 1993; 10(6):511-9. PubMed ID: 8123210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of LSD-25 with (-)-delta-9-trans-tetrahydrocannabinol (THC) and attempted cross tolerance between LSD and THC.
    Isbell H; Jasinski DR
    Psychopharmacologia; 1969; 14(2):115-23. PubMed ID: 5350620
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of chlordimeform on heart rate and body temperature of unanesthetized, unrestrained rats.
    Watkinson WP; Gordon CJ
    Toxicol Lett; 1987 Feb; 35(2-3):209-16. PubMed ID: 3824410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Cannabinoids Δ
    Thapa D; Cairns EA; Szczesniak AM; Toguri JT; Caldwell MD; Kelly MEM
    Cannabis Cannabinoid Res; 2018; 3(1):11-20. PubMed ID: 29450258
    [No Abstract]   [Full Text] [Related]  

  • 26. Very low doses of delta 8-THC increase food consumption and alter neurotransmitter levels following weight loss.
    Avraham Y; Ben-Shushan D; Breuer A; Zolotarev O; Okon A; Fink N; Katz V; Berry EM
    Pharmacol Biochem Behav; 2004 Apr; 77(4):675-84. PubMed ID: 15099912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An efficient new cannabinoid antiemetic in pediatric oncology.
    Abrahamov A; Abrahamov A; Mechoulam R
    Life Sci; 1995; 56(23-24):2097-102. PubMed ID: 7776837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular effects of (-)-11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl in rats.
    Vidrio H; Sánchez-Salvatori MA; Medina M
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):332-6. PubMed ID: 8856492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of hippocampal acetylcholine turnover in rats treated with (-)-delta 8-tetrahydrocannabinol and its 1',2'-dimethyl-heptyl homolog.
    Revuelta AV; Cheney DL; Costa E; Lander N; Mechoulam R
    Brain Res; 1980 Aug; 195(2):445-52. PubMed ID: 6249445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Systematic Review and Meta-Analysis of the In Vivo Haemodynamic Effects of Δ⁸-Tetrahydrocannabinol.
    Sultan SR; Millar SA; O'Sullivan SE; England TJ
    Pharmaceuticals (Basel); 2018 Jan; 11(1):. PubMed ID: 29385080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of cannabinoids on levels of acetylcholine and choline and on turnover rate of acetylcholine in various regions of the mouse brain.
    Tripathi HL; Vocci FJ; Brase DA; Dewey WL
    Alcohol Drug Res; 1987; 7(5-6):525-32. PubMed ID: 3620017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute and subacute bronchial effects of oral cannabinoids.
    Gong H; Tashkin DP; Simmons MS; Calvarese B; Shapiro BJ
    Clin Pharmacol Ther; 1984 Jan; 35(1):26-32. PubMed ID: 6690168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delta-8- and delta-9-tetrahydrocannabinol comparison in man by oral and intravenous administration.
    Hollister LE; Gillespie HK
    Clin Pharmacol Ther; 1973; 14(3):353-7. PubMed ID: 4698563
    [No Abstract]   [Full Text] [Related]  

  • 34. Vasoconstrictor actions of delta8- and delta9-tetrahydrocannabinol in the rat.
    Adams MD; Earnhardt JT; Dewey WL; Harris LS
    J Pharmacol Exp Ther; 1976 Mar; 196(3):649-56. PubMed ID: 4606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemistry and Pharmacology of Delta-8-Tetrahydrocannabinol.
    Abdel-Kader MS; Radwan MM; Metwaly AM; Eissa IH; Hazekamp A; ElSohly MA
    Molecules; 2024 Mar; 29(6):. PubMed ID: 38542886
    [No Abstract]   [Full Text] [Related]  

  • 36. Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses.
    Walsh KB; McKinney AE; Holmes AE
    Front Pharmacol; 2021; 12():777804. PubMed ID: 34916950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements.
    Wakshlag JJ; Cital S; Eaton SJ; Prussin R; Hudalla C
    Vet Med (Auckl); 2020; 11():45-55. PubMed ID: 32346530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of MDMB-FUBINACA in commercially available e-liquid formulations sold for use in electronic cigarettes.
    Peace MR; Krakowiak RI; Wolf CE; Poklis A; Poklis JL
    Forensic Sci Int; 2017 Feb; 271():92-97. PubMed ID: 28076838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The synthesis and pharmacological evaluation of adamantane-derived indoles: cannabimimetic drugs of abuse.
    Banister SD; Wilkinson SM; Longworth M; Stuart J; Apetz N; English K; Brooker L; Goebel C; Hibbs DE; Glass M; Connor M; McGregor IS; Kassiou M
    ACS Chem Neurosci; 2013 Jul; 4(7):1081-92. PubMed ID: 23551277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphine and delta 9-tetrahydrocannabinol: two-way cross tolerance for antinociceptive and heart-rate responses in the rat.
    Hine B
    Psychopharmacology (Berl); 1985; 87(1):34-8. PubMed ID: 2997827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.